Robuta

https://brands2life.com/our-work/hologic-uks-first-digital-cervical-cancer-technology-launch/ Hologic: UK’s first digital cervical cancer technology launch — Brands2Life cervical cancerhologicfirstdigitaltechnology https://www.techtransfer.nih.gov/patent/e-243-2020-0-jp-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER | Technology Transfer near infraredcombination therapycancer technologyphotoimmunotherapynir https://www.traderpower.com/itus-announces-issuance-of-patent-on-cancer-detection-technology/ $ITUS Announces Issuance of Patent on Cancer Detection Technology - Trader Power Sep 19, 2017 - SAN JOSE, CA–(September 18, 2017) – ITUS Corporation (NASDAQ: ITUS), today announced that the United States Patent and Trademark Office (“USPTO”) has issued... cancer detectionitusannouncesissuancepatent https://www.gpsj.co.uk/?p=7008 Genomics England deploys Sectra imaging technology in ground-breaking cancer data programme -... Mar 1, 2023 - Genomics England has completed installation of an enterprise imaging system that will help to support a world-pioneering initiative for cancer research. The... genomics englandimaging technologyground breakingdeployscancer https://www.biocom.org/lifelines-article/insights/nci-sbir-spotlights-pathways-to-6-7m-in-cancer-technology-funding/ NCI SBIR Spotlights Pathways to $6.7M in Cancer Technology Funding - Biocom Aug 29, 2025 - Biocom California recently welcomed National Cancer Institute (NCI) SBIR/STTR Program Directors for an in-depth discussion on federal funding opportunities... cancer technologyncisbirspotlightspathways https://www.techtransfer.nih.gov/patent/e-285-2016-2-gb-01 Glypican 2 As A Cancer Marker And Therapeutic Target | Technology Transfer as atherapeutic targettechnology transferglypicancancer https://www.technologynetworks.com/cancer-research/news/synthetic-forever-chemical-linked-to-risk-of-liver-cancer-364524 Synthetic “Forever Chemical” Linked to Risk of Liver Cancer | Technology Networks Exposure to a common chemical in the PFAS family is linked to an increased risk of liver cancer, as confirmed in human samples. liver cancersyntheticlinkedrisktechnology https://www.technologynetworks.com/genomics/news/red-wine-antioxidant-may-provide-new-cancer-therapy-options-207062 Red Wine Antioxidant May Provide New Cancer Therapy Options | Technology Networks Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in... red winecancer therapyantioxidantmayprovide https://www.technologynetworks.com/biopharma/news/ai-boosts-tumor-vaccine-development-for-skin-cancer-406268 AI Identifies Vaccine Targets for Skin Cancer | Technology Networks University of Arizona researchers used AI to identify neoantigens for a potential vaccine against cutaneous squamous cell carcinoma. for skincancer technologyidentifiesvaccinetargets https://au.headtopics.com/news/this-public-hospital-has-a-dazzling-cancer-technology-and-88364260 This public hospital has a 'dazzling' cancer technology and it's not where you think - Cancer... Oct 2, 2026 - A new cancer technology is now available to public hospital patients for the first time, but they must be in western NSW to access it. public hospitalcancer technologyyou thinkdazzling https://www.technologynetworks.com/drug-discovery/news/cancercausing-protein-turned-off-189598 Cancer-causing Protein “Turned Off” | Technology Networks Clinical trials on the horizon for experimental cancer drug. cancercausingproteintechnologynetworks https://child-health-research.centre.uq.edu.au/article/2024/02/vaccine-technology-research-gives-hope-children-brain-cancer Vaccine technology research gives hope to children with brain cancer - Child Health Research Centre... Feb 5, 2024 - Two leading University of Queensland researchers have joined forces to begin developing an mRNA vaccine for children with brain cancer. technology researchbrain cancerchild healthvaccinegives https://www.backushospital.org/about-us/news/news-detail?articleId=40396 This New Technology Makes Prostate Cancer Easier to Detect | Backus Hospital | CT Learn more about News Detail at backushospital.org new technologyprostate cancerbackus hospitalmakeseasier https://www.techtransfer.nih.gov/patent/e-243-2020-0-pct-02 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER | Technology Transfer near infraredcombination therapycancer technologyphotoimmunotherapynir https://www.technologynetworks.com/cancer-research/news/agalimmune-founded-to-develop-immunotherapeutics-for-cancer-185409 Agalimmune Founded to Develop Immunotherapeutics for Cancer | Technology Networks Funding will be used to continue the translation of Alphaject™ licensed from UMMS. cancer technologyfoundeddevelopimmunotherapeuticsnetworks https://www.technologynetworks.com/cancer-research/news/experimental-drug-enhances-immunotherapy-in-mouse-model-of-pancreatic-cancer-355488 Experimental Drug Enhances Immunotherapy in Mouse Model of Pancreatic Cancer | Technology Networks Findings of a study show that an experimental drug enhanced the benefit of immunotherapy to fight pancreatic cancer and in some mice, eliminated the cancer. experimental drugmouse modelpancreatic cancerenhancesimmunotherapy https://www.techtransfer.nih.gov/patent/e-184-2009-0-cn-06 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS | Technology Transfer technology transfercombinationimmunotherapycompositionscancer https://www.mskcc.org/research-advantage/support/rtm/compliance-review-and-oversight Research & Technology Management: Compliance Review and Oversight | Memorial Sloan Kettering Cancer... The office of Research Outreach and Compliance is charged with ensuring compliance with federal, state, institutional, and sponsor regulations with regard to... memorial sloan ketteringtechnology managementresearchcompliancereview https://www.techtransfer.nih.gov/patent/e-219-1995-1-pt-15 Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same | Technology... cancer antigenhumantyrosinaserelatedprotein